MEDNAX (MD) Tops Q2 EPS by 9c

MEDNAX (NYSE: MD) reported Q2 EPS of $0.41, $0.09 better than the analyst estimate of $0.32. Revenue for the quarter came in at $473 million versus the consensus estimate of $448.94 million.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Tilly's, Inc. (TLYS) Tops Q1 EPS by 44c ; offer guidance
• Jefferies, UBS downgrade Victoria's Secret as rally leaves limited upside